by CheckRare Staff | Feb 6, 2024
Kim Smith-Whitley, MD, chief medical officer for Real-World Evidence, Patient Advocacy, and External Collaborations at Pfizer and pediatric hematologist at the Children’s Hospital of Philadelphia, discusses recent advances in sickle cell disease treatment. ...
by CheckRare Staff | Feb 5, 2024
Judith Luker, head of Patient Engagement, Epilepsy and Rare Syndromes (Europe) at UCB Pharma, discusses the sudden unexpected death in epilepsy (SUDEP) communication gap and the importance of physician-patient conversations. SUDEP is the unexpected death...
by CheckRare Staff | Feb 4, 2024
Asya-Nina Varshavsky-Yanovsky, MD, PhD, Assistant Professor and Myeloma Program Lead at Fox Chase Cancer Center in Philadelphia, PA, discusses the safety of elranatamab in Black or African-American patient subgroups. Multiple myeloma is a form of cancer...
by CheckRare Staff | Feb 2, 2024
Bill Grambley, CEO of AllazoHealth, explains how his company attacks health inequalities by providing personalized pharmaceutical care with artificial intelligence (AI)-based platforms. AI-based platforms can be utilized to predict patient behavior and...
by CheckRare Staff | Feb 1, 2024
Richard F. Riedel, MD, Medical Oncologist, Duke Health, discusses tyenosynovial giant cell tumors (TGCT), including: – Challenges of diagnosing these rare, benign tumors – Current management strategies – Emerging treatment options – Advice to...
